CClinicalTrials.gg
Status unknownNCT05795075Updated Aug 3, 2023

Randomized Control Trial Comparing CMPAT and MAT for Lumbar Puncture

An interventional study of Computerized Modified Paramedian Approach Technique and Conventional Midline Approach Technique in a Randomized Controlled Trial, sponsored by Fujian Medical University Union Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-08-03.

Sponsored by Fujian Medical University Union Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The lumbar puncture (LP) technique is a widely utilized method for diagnosis and treatment purposes. Recently, the paramedian approach technique (PAT) has garnered increasing interest due to its advantages over the midline approach technique (MAT), which has traditionally been used for LP in clinical practice . Utilizing digital virtual human and computer simulation techniques, a new path has been proposed for the computerized modified paramedian approach technique (CMPAT). As such, the objective of the present study is to present a randomized controlled trial (RCT) protocol to investigate and compare the effects of CMPAT versus MAT in patients requiring LP.

02

Conditions studied

  • a Randomized Controlled Trial
03

In context

Lead sponsor

Fujian Medical University Union Hospital is the lead sponsor of 100 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 18-70 years. Indication for LP.(Diagnostic lumbar puncture:Cerebrospinal fluid composition analysis,Cerebrospinal fluid pressure measurement;Cerebrospinal fluid release or lumbar Contiuous drainage of fluid,Intrathecal injection of lumbar cistern, etc.) Informed consent. Sufficient knowledge of the Chinese language to complete forms and follow instructions independently.

Exclusion criteria

Exclusion Criteria:

  • Cerebral hernia or high Cerebrospinal fluid pressure that might lead to Cerebral hernia.

Treatment with oral anticoagulant or anti-small plate(3 days or less)or coagulation disorders, various factors leading to a higher risk of bleeding.

Local infection or skin breakdown. Previous surgery on Lumbar spine segments. Pregnancy or lactation Severe somatic or psychiatric illness.(Severe anxiety or depression, etc.) Failure to be followed up as needed or worries about the potential risks of the study.

Failure to provide written informed consent or follow the protocol requirements.

Expected survival time being less than 1 month. Plan to emigrate within 1 month. Other conditions that are unsuitable for clinical research.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Computerized Modified Paramedian Approach Technique

    The L3-4 inter-laminar space will be selected as the target for puncture, and in the longitudinal direction, 1.0-1.5cm will be opened beside the upper edge of the spinous process (tip) of the lower vertebra as the entry point. The lumbar puncture needle will be inserted vertically along the axis of the anesthesia needle. The puncture path will be maintained completely perpendicular to the skin until the needle reached the PLTLF (posterior layer of the thoracolumbar fascia), where some resistance will be felt. The puncture direction is adjusted as needed. The tip of the needle will be tilted 20±10° in the sagittal direction and 15±5° inward such that the tip will point at the midpoint of the spinal canal. After the needle reaches the PLTLF, it will be further inserted 3-7 cm.

    Procedure: Computerized Modified Paramedian Approach Technique

  • Experimental
    Conventional Midline Approach Technique

    Puncture will be performed on the posterior median line near the midpoint of the L3-4 Space of spinous process. The lumbar puncture needle will be inserted vertically along the axis of the anesthesia needle, or the tip of the needle will be tilted 15° in the sagittal direction toward the head, so that the needle path is parallel to the space of spinous process.

    Procedure: Conventional Midline Approach Technique

Interventions

  • ProcedureComputerized Modified Paramedian Approach Technique

    Computerized Modified Paramedian Approach Technique ( CMPAT )

  • ProcedureConventional Midline Approach Technique

    Conventional Midline Approach Technique

06

What researchers measure

Primary outcomes

  1. Number of puncture attempts in case of successful LP

    Time frame: 1 day

  2. LP success rate

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
  • Fujian Medical University Union Hospital
    Fuzhou, Fujian, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05795075
Lead sponsor
Fujian Medical University Union Hospital
Responsible party
Sponsor
First posted
Apr 3, 2023
Start date
Jun 30, 2023
Primary completion
Mar 30, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Aug 3, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion